Recent Finacing
Recent Raise
Nuvig Therapeutics is a clinical-stage biotech developing engineered recombinant Fc protein therapeutics, including NVG-2089, that engage type II Fc receptors to restore immune regulation and treat autoimmune diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Nuvig Therapeutics.
